James J. Zhu
Partner, Lawyer for Jun He Law Offices
作为 Jun He律师事务所的合伙人之一，James Zhu博士负责加强中美公司知识产权的相关研究。
詹姆斯的研究包括专利获取意见，分析及策略，诉讼，技术许可。主要专注于生命科学，材料科学，医疗器械，电子等。
作为中国与世界其他国家之间的沟通渠道，在快速发展和充满挑战的环境下，James代表国际客户在中国获得和实施其知识产权（IP）的权利。不仅这样，James还帮助国际客户提升知识产权资产的价值，降低知识产权风险，并通过全面尽职的调查，咨询，采购，诉讼和跨境许可和合作增加商业机会。
在加入 Jun He前，James 曾在Lyon & Lyon and Perkins Coie律师事务所工作。他是Perkins Coie's的洛杉矶办事处的合伙人和其北京办事处的执行合伙人。在90年代后期，James是GanTech国际的一位联合创始人。GanTech国际是初创于美国硅谷的风险投资支持公司。在GanTech，他是资金筹集，法律和业务开发活动的法律总顾问。在90年代初，James 是 Merck & Co.的一位研究科学家。
James毕业于上海复旦大学。在他就学的七学年中，他获得了加州技术研究所的博士学位和哥伦比亚大学的JD＆MBA学位和学士学位。
在2004-2009年，James是生物技术工业组织（BIO）的中国国际代表团的组织者。同时他也联络中国新兴的生物技术公司进入BIO的年度会议。James是BayHelix集团（董事长，2008-2009）和Wu-Ray协会（2006-2007年）的董事会成员。 2008年，商业周刊选出James Zhu作为在中美社区最有影响力的“海龟”（海归美国）之一。
作为一个有经验的演讲者和作者，James写了很多著名书籍中的一些章节，如“深度思考：在亚洲知识产权客户策略”和“中国生物制药的发展”等。他也为期刊撰写文章，如IP业务和法律，中国日报与国家法律杂志等。
Dr. James Zhu is a partner at Jun He Law Offices responsible for strengthening the firm’s IP practice in China by splitting his time between China and the US.
James’ practice include patent procurement, opinion, analysis & strategy, litigation, technology licensing, primarily focusing on life sciences, material sciences, medical device, and electronics.
As a conduit between China and the rest of the world, James represents international clients to obtain and enforce their intellectual property (IP) rights in the fast-evolving and challenging IP environment in China. In particular, James helps international clients to enhance the value of IP assets, lower IP risks, and increase commercialization opportunities through comprehensive due diligence, counseling, procurement, litigation and cross-border licensin and collaboration.
Prior to joining Jun He, James worked at Lyon & Lyon and Perkins Coie. James was a partner in Perkins Coie's Los Angeles Office and the Managing Partner of its Beijing Office. In the late 90s, James was a co-founder & General Counsel of GanTech International, a venture backed start up in Silicon Valley where he spearheaded fund raising, legal and business development activities. In the early 90s, James was a research scientist at Merck & Co..
James is a member of the State Bar of California and a patent attorney registered topractice before the US Patent & Trademark Office.
James graduated from Fudan University Shanghai. With a total of seven academic years, James earned a Ph.D. Degree from the California Institute of Technology and J.D. & MBA dual degrees from Columbia University.
James was the International Delegation Organizer for China in Biotechnology Industry Organization (BIO) in 2004-2009 and organize emerging Chinese biotechnology companies into BIO’s annual meetings. James sat on the Boards of BayHelix Group (Chairman, 2008-2009) and Wu-Ray Society (2006-2007). In 2008, the BusinessWeek elected James as one of most influential "sea turtles" (US returnees) in the Sino-American community.
A frequent speaker and author, James authored chapters in books such as “Inside the Mind: IP Client Strategies in Asia” and “Advances in Biopharmaceutical in China”. James also wrote articles for journals such as IP Business & Law, China Daily & National Law Journal.
詹姆斯的研究包括专利获取意见，分析及策略，诉讼，技术许可。主要专注于生命科学，材料科学，医疗器械，电子等。
作为中国与世界其他国家之间的沟通渠道，在快速发展和充满挑战的环境下，James代表国际客户在中国获得和实施其知识产权（IP）的权利。不仅这样，James还帮助国际客户提升知识产权资产的价值，降低知识产权风险，并通过全面尽职的调查，咨询，采购，诉讼和跨境许可和合作增加商业机会。
在加入 Jun He前，James 曾在Lyon & Lyon and Perkins Coie律师事务所工作。他是Perkins Coie's的洛杉矶办事处的合伙人和其北京办事处的执行合伙人。在90年代后期，James是GanTech国际的一位联合创始人。GanTech国际是初创于美国硅谷的风险投资支持公司。在GanTech，他是资金筹集，法律和业务开发活动的法律总顾问。在90年代初，James 是 Merck & Co.的一位研究科学家。
James毕业于上海复旦大学。在他就学的七学年中，他获得了加州技术研究所的博士学位和哥伦比亚大学的JD＆MBA学位和学士学位。
在2004-2009年，James是生物技术工业组织（BIO）的中国国际代表团的组织者。同时他也联络中国新兴的生物技术公司进入BIO的年度会议。James是BayHelix集团（董事长，2008-2009）和Wu-Ray协会（2006-2007年）的董事会成员。 2008年，商业周刊选出James Zhu作为在中美社区最有影响力的“海龟”（海归美国）之一。
作为一个有经验的演讲者和作者，James写了很多著名书籍中的一些章节，如“深度思考：在亚洲知识产权客户策略”和“中国生物制药的发展”等。他也为期刊撰写文章，如IP业务和法律，中国日报与国家法律杂志等。
Dr. James Zhu is a partner at Jun He Law Offices responsible for strengthening the firm’s IP practice in China by splitting his time between China and the US.
James’ practice include patent procurement, opinion, analysis & strategy, litigation, technology licensing, primarily focusing on life sciences, material sciences, medical device, and electronics.
As a conduit between China and the rest of the world, James represents international clients to obtain and enforce their intellectual property (IP) rights in the fast-evolving and challenging IP environment in China. In particular, James helps international clients to enhance the value of IP assets, lower IP risks, and increase commercialization opportunities through comprehensive due diligence, counseling, procurement, litigation and cross-border licensin and collaboration.
Prior to joining Jun He, James worked at Lyon & Lyon and Perkins Coie. James was a partner in Perkins Coie's Los Angeles Office and the Managing Partner of its Beijing Office. In the late 90s, James was a co-founder & General Counsel of GanTech International, a venture backed start up in Silicon Valley where he spearheaded fund raising, legal and business development activities. In the early 90s, James was a research scientist at Merck & Co..
James is a member of the State Bar of California and a patent attorney registered topractice before the US Patent & Trademark Office.
James graduated from Fudan University Shanghai. With a total of seven academic years, James earned a Ph.D. Degree from the California Institute of Technology and J.D. & MBA dual degrees from Columbia University.
James was the International Delegation Organizer for China in Biotechnology Industry Organization (BIO) in 2004-2009 and organize emerging Chinese biotechnology companies into BIO’s annual meetings. James sat on the Boards of BayHelix Group (Chairman, 2008-2009) and Wu-Ray Society (2006-2007). In 2008, the BusinessWeek elected James as one of most influential "sea turtles" (US returnees) in the Sino-American community.
A frequent speaker and author, James authored chapters in books such as “Inside the Mind: IP Client Strategies in Asia” and “Advances in Biopharmaceutical in China”. James also wrote articles for journals such as IP Business & Law, China Daily & National Law Journal.
关注普渡GCC公共平台，及时接收GCC最新活动消息，普渡校园动态。
GCC公共主页微信号：gccpurdue
GCC公共主页微信号：gccpurdue
